Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

International Urology and Nephrology

Volumn 42, Issue 3, 2010, Pages 667-671

  Hekal, Ihab A ^a   El Tabey, Nasr A ^a   Nabeeh, Mohamed Adel ^a   El Assmy, Ahmed ^a   El Hameed, Mohamed Abd ^b   Nabeeh, Adel ^a   Ibrahiem, Elhousseiny I ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Epstein criteria; Prediction; Prostate cancer; Screening test

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CELL INFILTRATION; CLINICAL ARTICLE; CONTEMPORARY EPSTEIN CRITERIA; CONTROLLED STUDY; CRITERION VARIABLE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MIDDLE EAST; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SEMINAL VESICLE; VALIDATION PROCESS;

AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 78549239880     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9670-6     Document Type: Article

References (12)

1. JI Epstein PC Walsh M Carmichael CB Brendler 1994 Pathologic and clinical findings to predict tumor extent of non palpable (stage T1c) prostate cancer JAMA 271 368 374 1:STN:280:DyaK2c7htFalsA%3D%3D 10.1001/jama.271.5.368 7506797 (Pubitemid 24037911)
2. RW Allan H Sanderson JI Epstein 2003 Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density J Urol 170 370 372 10.1097/01.ju.0000074747.72993.cb 12853777
3. TY Chan DY Chan KL Stutzman JI Epstein 2001 Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? J Urol 166 2181 2184 1:STN:280:DC%2BD3MnksVeisg%3D%3D 10.1016/S0022-5347(05)65530-9 11696731
4. PJ Bastian LA Mangold JI Epstein AW Partin 2004 Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis Cancer 101 2001 2005 10.1002/cncr.20586 15372478 (Pubitemid 39425375)
5. C Jeldres N Suardi J Walz GC Hutterer, et al. 2008 Validation of the contemporary epstein criteria for insignificant prostate cancer in European men Eur Urol 54 6 1306 1313 10.1016/j.eururo.2007.11.057 18083294
6. European Guideline (2008) Edition 2008, Prostate cancer section, p 7
7. FK-H Chun T Steuber A Erbersdobler, et al. 2006 Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology Eur Urol 49 820 826 10.1016/j.eururo.2005.11.007 16439050
8. A Briganti SF Shariat FK Chun, et al. 2007 Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin BJU Int 100 528 532 1:CAS:528: DC%2BD2sXhtVynsLbN 10.1111/j.1464-410X.2007.07005.x 17573893 (Pubitemid 47205464)
9. M Ghafoor R Schuyten A Bener 2003 Epidemiology of prostate cancer in United Arab Emirates Med J Malaysia 58 5 712 716 1:STN:280: DC%2BD2c3ptVCktA%3D%3D 15190657 (Pubitemid 38480485)
10. A Sadjadi M Nooraie A Ghorbani M Alimohammadian, et al. 2007 The incidence of prostate cancer in Iran: results of a population-based cancer registry Arch Iran Med 10 4 481 485 17903053
11. FK Chun A Briganti SF Shariat, et al. 2006 Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation BJU Int 98 329 334 10.1111/j.1464-410X.2006.06262.x 16879673
12. RW Veltri MC Miller LA Mangold, et al. 2002 Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge J Urol 168 100 104 10.1016/S0022-5347(05)64839-2 12050500